- Home
- KYMR vs VEON Comparison
KYMR vs VEON Comparison
Compare KYMR & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- VEON
- Stock Information
- Founded
- KYMR 2015
- VEON 1992
- Country
- KYMR United States
- VEON United Arab Emirates
- Employees
- KYMR N/A
- VEON N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- VEON Telecommunications Equipment
- Sector
- KYMR Health Care
- VEON Telecommunications
- Exchange
- KYMR Nasdaq
- VEON Nasdaq
- Market Cap
- KYMR 4.2B
- VEON 3.6B
- IPO Year
- KYMR 2020
- VEON 1996
- Fundamental
- Price
- KYMR $56.83
- VEON $51.47
- Analyst Decision
- KYMR Strong Buy
- VEON Strong Buy
- Analyst Count
- KYMR 17
- VEON 1
- Target Price
- KYMR $61.65
- VEON $60.00
- AVG Volume (30 Days)
- KYMR 910.5K
- VEON 108.4K
- Earning Date
- KYMR 10-30-2025
- VEON 11-13-2025
- Dividend Yield
- KYMR N/A
- VEON N/A
- EPS Growth
- KYMR N/A
- VEON N/A
- EPS
- KYMR N/A
- VEON 13.63
- Revenue
- KYMR $44,711,000.00
- VEON $4,148,000,000.00
- Revenue This Year
- KYMR $62.11
- VEON $10.39
- Revenue Next Year
- KYMR N/A
- VEON $7.53
- P/E Ratio
- KYMR N/A
- VEON $3.78
- Revenue Growth
- KYMR N/A
- VEON 7.27
- 52 Week Low
- KYMR $19.45
- VEON $29.29
- 52 Week High
- KYMR $59.00
- VEON $64.00
- Technical
- Relative Strength Index (RSI)
- KYMR 65.68
- VEON 42.90
- Support Level
- KYMR $54.09
- VEON $51.00
- Resistance Level
- KYMR $59.00
- VEON $53.76
- Average True Range (ATR)
- KYMR 2.39
- VEON 1.95
- MACD
- KYMR 0.30
- VEON -0.21
- Stochastic Oscillator
- KYMR 80.00
- VEON 9.01
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.